RDGL
Price
$0.07
Change
-$0.00 (-0.00%)
Updated
Nov 18 closing price
Capitalization
25.01M
Intraday BUY SELL Signals
RSMDF
Price
$24.00
Change
-$3.69 (-13.33%)
Updated
Nov 18 closing price
Capitalization
35.76B
63 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

RDGL vs RSMDF

Header iconRDGL vs RSMDF Comparison
Open Charts RDGL vs RSMDFBanner chart's image
Vivos
Price$0.07
Change-$0.00 (-0.00%)
Volume$1.53M
Capitalization25.01M
Resmed
Price$24.00
Change-$3.69 (-13.33%)
Volume$431
Capitalization35.76B
RDGL vs RSMDF Comparison Chart in %
RDGL
Daily Signal:
Gain/Loss:
RSMDF
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
RDGL vs. RSMDF commentary
Nov 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RDGL is a Hold and RSMDF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 20, 2025
Stock price -- (RDGL: $0.05 vs. RSMDF: $24.64)
Brand notoriety: RDGL and RSMDF are both not notable
RDGL represents the Medical/Nursing Services, while RSMDF is part of the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: RDGL: 1237% vs. RSMDF: 3%
Market capitalization -- RDGL: $25.01M vs. RSMDF: $35.76B
RDGL [@Medical/Nursing Services] is valued at $25.01M. RSMDF’s [@Pharmaceuticals: Other] market capitalization is $35.76B. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $219.36B to $0. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $200.16B to $0. The average market capitalization across the [@Medical/Nursing Services] industry is $5.63B. The average market capitalization across the [@Pharmaceuticals: Other] industry is $11.71B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RDGL’s FA Score shows that 0 FA rating(s) are green whileRSMDF’s FA Score has 0 green FA rating(s).

  • RDGL’s FA Score: 0 green, 5 red.
  • RSMDF’s FA Score: 0 green, 5 red.
According to our system of comparison, RSMDF is a better buy in the long-term than RDGL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RDGL’s TA Score shows that 4 TA indicator(s) are bullish while RSMDF’s TA Score has 2 bullish TA indicator(s).

  • RDGL’s TA Score: 4 bullish, 5 bearish.
  • RSMDF’s TA Score: 2 bullish, 8 bearish.
According to our system of comparison, RDGL is a better buy in the short-term than RSMDF.

Price Growth

RDGL (@Medical/Nursing Services) experienced а -38.85% price change this week, while RSMDF (@Pharmaceuticals: Other) price change was -3.52% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -5.47%. For the same industry, the average monthly price growth was -8.60%, and the average quarterly price growth was +8.79%.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -2.03%. For the same industry, the average monthly price growth was -0.29%, and the average quarterly price growth was +8.18%.

Reported Earning Dates

RSMDF is expected to report earnings on Jan 22, 2026.

Industries' Descriptions

@Medical/Nursing Services (-5.47% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

@Pharmaceuticals: Other (-2.03% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RSMDF($35.8B) has a higher market cap than RDGL($25M). RSMDF YTD gains are higher at: 8.721 vs. RDGL (-52.132). RSMDF has higher annual earnings (EBITDA): 2B vs. RDGL (-3.04M). RDGL has less debt than RSMDF: RDGL (296K) vs RSMDF (846M). RSMDF has higher revenues than RDGL: RSMDF (5.26B) vs RDGL (51.7K).
RDGLRSMDFRDGL / RSMDF
Capitalization25M35.8B0%
EBITDA-3.04M2B-0%
Gain YTD-52.1328.721-598%
P/E RatioN/A25.22-
Revenue51.7K5.26B0%
Total Cash2.66MN/A-
Total Debt296K846M0%
FUNDAMENTALS RATINGS
RDGL vs RSMDF: Fundamental Ratings
RDGL
RSMDF
OUTLOOK RATING
1..100
352
VALUATION
overvalued / fair valued / undervalued
1..100
96
Overvalued
34
Fair valued
PROFIT vs RISK RATING
1..100
8278
SMR RATING
1..100
9937
PRICE GROWTH RATING
1..100
8138
P/E GROWTH RATING
1..100
7066
SEASONALITY SCORE
1..100
7575

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

RSMDF's Valuation (34) in the null industry is somewhat better than the same rating for RDGL (96). This means that RSMDF’s stock grew somewhat faster than RDGL’s over the last 12 months.

RSMDF's Profit vs Risk Rating (78) in the null industry is in the same range as RDGL (82). This means that RSMDF’s stock grew similarly to RDGL’s over the last 12 months.

RSMDF's SMR Rating (37) in the null industry is somewhat better than the same rating for RDGL (99). This means that RSMDF’s stock grew somewhat faster than RDGL’s over the last 12 months.

RSMDF's Price Growth Rating (38) in the null industry is somewhat better than the same rating for RDGL (81). This means that RSMDF’s stock grew somewhat faster than RDGL’s over the last 12 months.

RSMDF's P/E Growth Rating (66) in the null industry is in the same range as RDGL (70). This means that RSMDF’s stock grew similarly to RDGL’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
RDGLRSMDF
RSI
ODDS (%)
Bullish Trend 2 days ago
89%
Bearish Trend 2 days ago
35%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
25%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
30%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
26%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
40%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
34%
Advances
ODDS (%)
Bullish Trend 9 days ago
84%
Bullish Trend 8 days ago
25%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 17 days ago
67%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
29%
Aroon
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
32%
View a ticker or compare two or three
Interact to see
Advertisement
RDGL
Daily Signal:
Gain/Loss:
RSMDF
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NYAX43.353.52
+8.84%
Nayax Ltd
LCCCU10.35N/A
N/A
Lakeshore Acquisition III Corp
AGCO101.21-0.89
-0.87%
AGCO Corp
EPRX6.21-0.16
-2.51%
Eupraxia Pharmaceuticals
GNTA1.79-0.20
-10.05%
Genenta Science SpA

RDGL and

Correlation & Price change

A.I.dvisor tells us that RDGL and IART have been poorly correlated (+20% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that RDGL and IART's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RDGL
1D Price
Change %
RDGL100%
-23.61%
IART - RDGL
20%
Poorly correlated
-2.36%
RYLPF - RDGL
8%
Poorly correlated
N/A
SAFLY - RDGL
4%
Poorly correlated
N/A
POSC - RDGL
4%
Poorly correlated
+1.71%
RSMDF - RDGL
-0%
Poorly correlated
+2.67%
More